Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
about
Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseInhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsPotential Roles of Adropin in Central Nervous System: Review of Current LiteratureThe neurology of mTORSubcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disordersProtein Kinases and Parkinson's DiseasePro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neuronsResistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activationRTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activationNeurotrophic effects of a cyanine dye via the PI3K-Akt pathway: attenuation of motor discoordination and neurodegeneration in an ataxic animal modelMicrotubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotectiveAn endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.Out FOXing Parkinson disease: where development meets neurodegeneration.Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neuronsGlutamate controls growth rate and branching of dopaminergic axons.DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B.Naringin: a protector of the nigrostriatal dopaminergic projection.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.A neuroprotective role for angiogenin in models of Parkinson's diseaseLanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt.The JNK- and AKT/GSK3β- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivationAkt1 mediates neuronal differentiation in zebrafish via a reciprocal interaction with notch signalingProgrammed cell death and new discoveries in the genetics of parkinsonism.Intracellular signalling pathways in dopamine cell death and axonal degeneration.Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.Axon degeneration in Parkinson's diseaseInhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative diseaseFate mapping and lineage analyses demonstrate the production of a large number of striatal neuroblasts after transforming growth factor alpha and noggin striatal infusions into the dopamine-depleted striatumTreatment of Parkinson's disease with trophic factors.Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic modelsCell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.Huntington's disease and Group I metabotropic glutamate receptors.
P2860
Q24307730-30E4614E-FFC6-4B59-A47C-30BAD6AEF0CCQ24319028-F9E66D07-33F2-4B35-BCF0-C8D4E86C4370Q24609725-C47B37EC-84AA-4B72-9B3D-472CC4E396A1Q24673667-C10FDA55-C5AF-481A-B006-D673CE5F7755Q26742073-8961F114-C633-4983-B527-9179B1BECF45Q26824286-5C1A0B8C-A5CB-45B6-8795-F23937E927FCQ27022790-F52B7203-EE5A-4943-AF8A-60381FDACDD4Q28067636-6BE084FF-53DC-4A72-8FB7-852C9183E070Q28473591-9E16C5F6-0556-4EF5-A728-359D4377EDEAQ28477043-B5F328F3-73A0-46F7-85D4-6DD53E0C2BF9Q28568796-81B3B2D4-0839-4114-BAB8-B7C38ACB6E78Q28742839-810EDCAF-19F6-4A9E-8D46-77640F95C400Q30539763-88CC86CD-338C-4AD0-96F7-EE2C53D6EDA6Q33292773-3817C942-86C9-468A-B46C-6C5EE67D4EF8Q33311344-BD76B079-93EA-47A2-B915-53537A87CBDCQ33502757-4EA853C4-3AAD-47AE-944E-21923585D646Q33602001-4DA4D2AF-B71F-4182-BB6E-1AC332462B26Q33637339-10EBDAB9-DFF0-4F7F-90B1-570492DFB001Q33734076-5BDFA6A4-7813-4E1C-AAAC-5F9D40E0B402Q33748698-07307EF0-56E0-41AE-82A7-E29C12AE0B80Q33787324-63C84E10-2C29-4DB2-8E85-552916B8D94DQ33797449-4BFB2732-E8D9-40FC-816C-9FEF19A61975Q33960102-2F302E75-2977-419F-BF13-FAD6A0FBAC76Q34024770-D7D436C7-2CB4-411C-8855-94DA1AF51E15Q34441337-C3CF7E01-D4B8-49AF-9A29-11F8BF90493BQ34442409-E2FD292F-4020-4E3D-916E-7292C77DE0E4Q34559260-7C51112E-561C-4B02-95C1-1ACDD5D64BABQ34859364-2F0DAE91-1E6E-4DE7-B78D-3FD3FD6A96DFQ34936423-F4789FFB-0C29-405C-B022-B3AFFF14DDE2Q35154720-A9AC1D92-9060-4CDB-A756-32EE46AA33A1Q35196491-5004C1DB-F267-43AF-8836-D228C5AD59CFQ35822548-907231C4-6CF2-493E-813D-BFE6E3114E5CQ35923102-167D9983-E72D-4D3E-80FD-8BD9062690B6Q36776350-89902B2C-2D9E-42F3-AAA3-056480B93401Q37113840-85D63ED1-62E8-42D3-BC79-C65C3077D214Q37131259-160125A1-2287-44A5-B1C0-00CA3FC8DD8EQ37278480-201ED60A-6EAF-4563-B274-3D20C69D3268Q37356319-46718B1E-477D-4167-8E6A-962738ADF749Q37376117-45A68D84-5D1A-4E60-95AB-58240D190A39Q37820343-8369D567-D1F4-493E-8BF5-15146D5F667E
P2860
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@ast
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@en
type
label
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@ast
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@en
prefLabel
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@ast
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@en
P2093
P2860
P356
P1476
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
@en
P2093
Claire Henchcliffe
Margarita Rzhetskaya
Matthew J During
Nikolai Kholodilov
Ross Bland
Tatyana Kareva
Vincent Ries
P2860
P304
18757-18762
P356
10.1073/PNAS.0606401103
P407
P577
2006-11-20T00:00:00Z